Overview
Retatrutide is an engineered peptide designed to concurrently engage three distinct metabolic pathways. By functioning as a GIP, GLP-1, and glucagon receptor tri-agonist, it allows researchers to study the synergistic effects of multi-hormone targeting on weight homeostasis, insulin sensitivity, and adipose tissue breakdown.
Disclaimer: This product is synthesized and distributed strictly for independent laboratory research and development purposes. It is not intended for diagnostic, therapeutic, or direct human use.





